D
Cullinan Therapeutics, Inc. CGEM
$9.07 $0.111.23% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses -7.00% 9.04%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -0.09% 12.68%
Operating Income 0.09% -12.68%
Income Before Tax -2.04% -17.18%
Income Tax Expenses -- --
Earnings from Continuing Operations -1.79% -17.47%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -1.79% -17.47%
EBIT 0.09% -12.68%
EBITDA 0.09% -12.69%
EPS Basic -1.23% -16.99%
Normalized Basic EPS -1.48% -16.71%
EPS Diluted -1.23% -16.99%
Normalized Diluted EPS -1.48% -16.71%
Average Basic Shares Outstanding 0.55% 0.42%
Average Diluted Shares Outstanding 0.55% 0.42%
Dividend Per Share -- --
Payout Ratio -- --